178 related articles for article (PubMed ID: 34272498)
1. Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases.
Lovero D; D'Oronzo S; Palmirotta R; Cafforio P; Brown J; Wood S; Porta C; Lauricella E; Coleman R; Silvestris F
Br J Cancer; 2022 Feb; 126(3):419-429. PubMed ID: 34272498
[TBL] [Abstract][Full Text] [Related]
2. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
3. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
[TBL] [Abstract][Full Text] [Related]
4. Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.
Zou L; Imani S; Maghsoudloo M; Shasaltaneh MD; Gao L; Zhou J; Wen Q; Liu S; Zhang L; Chen G
Oncol Rep; 2020 Sep; 44(3):1075-1093. PubMed ID: 32705227
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
7. RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
Lang JE; Ring A; Porras T; Kaur P; Forte VA; Mineyev N; Tripathy D; Press MF; Campo D
Ann Surg Oncol; 2018 Aug; 25(8):2261-2270. PubMed ID: 29868978
[TBL] [Abstract][Full Text] [Related]
8. Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Haas NB; LaRiviere MJ; Buckingham TH; Cherkas Y; Calara-Nielsen K; Foulk B; Patel J; Gross S; Smirnov D; Vaughn DJ; Amaravadi R; Wellen KE; Savitch SL; Majmundar KJ; Black TA; Yee SS; He M; Min EJ; Long Q; Jones JO; Pal SK; Carpenter EL
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):448-456. PubMed ID: 33009489
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
Giuliano M; Giordano A; Jackson S; De Giorgi U; Mego M; Cohen EN; Gao H; Anfossi S; Handy BC; Ueno NT; Alvarez RH; De Placido S; Valero V; Hortobagyi GN; Reuben JM; Cristofanilli M
Breast Cancer Res; 2014 Sep; 16(5):440. PubMed ID: 25223629
[TBL] [Abstract][Full Text] [Related]
10. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
[TBL] [Abstract][Full Text] [Related]
12. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Rizzo FM; Vesely C; Childs A; Marafioti T; Khan MS; Mandair D; Cives M; Ensell L; Lowe H; Akarca AU; Luong T; Caplin M; Toumpanakis C; Krell D; Thirlwell C; Silvestris F; Hartley JA; Meyer T
Br J Cancer; 2019 Feb; 120(3):294-300. PubMed ID: 30636773
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
[TBL] [Abstract][Full Text] [Related]
16. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
17. Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo.
Li S; Yang S; Shi J; Ding Y; Gao W; Cheng M; Sun Y; Xie Y; Sang M; Yang H; Geng C
Neoplasma; 2021 Jan; 68(1):31-39. PubMed ID: 32940042
[TBL] [Abstract][Full Text] [Related]
18. AR Expression in Breast Cancer CTCs Associates with Bone Metastases.
Aceto N; Bardia A; Wittner BS; Donaldson MC; O'Keefe R; Engstrom A; Bersani F; Zheng Y; Comaills V; Niederhoffer K; Zhu H; Mackenzie O; Shioda T; Sgroi D; Kapur R; Ting DT; Moy B; Ramaswamy S; Toner M; Haber DA; Maheswaran S
Mol Cancer Res; 2018 Apr; 16(4):720-727. PubMed ID: 29453314
[TBL] [Abstract][Full Text] [Related]
19. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
